## Abstract Thirty patients with advanced measurable colorectal cancer were randomized to receive either methotrexate (MTX) 200 mg/m^2^ or 40 mg/m^2^, followed in four hours by 5βfluorouracil (5βFU) 600 mg/m^2^. Patients receiving the higher dose MTX were given leucovorin rescue 24 hours later. Eig
Sequential methotrexate/5-fluorouracil in advanced colorectal cancer treatment
β Scribed by Evaristo Maiello; Francesco Giotta; Francesco Giuliani; Emanuele Naglieri; Giuseppe Colucci
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 442 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recent in vitro and animal tumor studies suggest that sequential methotrexate (MTX) and 5-fluorouracil (5-FU) may be much more tumoricidal than either drug when used alone or in conventional combinations. Seventeen evaluable female patients with advanced carcinoma of the breast were treated with MTX
## Background and Objectives: The present study compared the effects of sequential methotrexate and fluorouracil followed by leucovorin rescue (MFL), as an adjuvant chemotherapy versus a combination of tegafur (UFT) and mitomycin C (MMC), on patient survival and recurrence after surgery for colore
## Abstract Consecutive studies were undertaken in advanced colorectal adenocarcinoma, comparing two different schedules of the combination methylβCCNU, 6βthioguanine, and 5βfluorouracil in 89 patients. The two schedules exhibited similar efficacies, with a combined complete and partial remission r